OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA circ‐TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA
Xiaojuan Pan, Bo Huang, Qiang Ma, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4
Yunfei Wang, Taowei Yang, Qihao Li, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
Nan Zhang, Xinjia Wang, Yu Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1

Deciphering the generation of heterogeneity in esophageal squamous cell carcinoma metastasis via single-cell multiomics analysis
Kaiwen Sheng, Jun Chen, Ruitang Xu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance
Zhibin Zhang, Z.M. Guo K.L. Gao, Huimin Fang, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 867-888
Closed Access | Times Cited: 7

CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure
Tushuai Li, Yue Gu, Baocai Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 15

m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation
Baoxiang Chen, Yuntian Hong, Xiang Zhai, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 14

Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors
Heng Zhou, Qiang Sun, Ming-Liang Feng, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4247-4265
Open Access | Times Cited: 13

ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway
Yang Ji, Chuangye Ni, Yanjun Shen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Multifaceted roles of insulin‑like growth factor 2 mRNA binding protein 2 in human cancer (Review)
Jianan Shen, Youxiang Ding
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access

CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA
Chunyu Zhang, Yuan Li, Qiaojian Zou, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4

RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression
Junwu Ren, Bo Huang, Wei Li, et al.
Translational Oncology (2024) Vol. 42, pp. 101904-101904
Open Access | Times Cited: 4

Therapeutic SHPRH-146aa encoded by circ-SHPRH dynamically upregulates P21 to inhibit CDKs in neuroblastoma
Saishuo Chang, Dong Ren, Li Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217120-217120
Closed Access | Times Cited: 4

HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy
Essak S. Khan, Tobias Däinghaus
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4

N-methyladenosine enhances the expression of TGF-β-SMAD signaling family to inhibit cell growth and promote cell metastasis
Bo Peng, Shuwen Cheng, H. Wang, et al.
Cancer Letters (2024) Vol. 603, pp. 217195-217195
Closed Access | Times Cited: 4

SERPINH1 secretion by cancer-associated fibroblasts promotes hepatocellular carcinoma malignancy through SENP3-mediated SP1/SQLE pathway
Hua Xiao, Zhaoying Yao, Tao Li, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114259-114259
Closed Access

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes
Lili Wang, Min Zhang, Kelei Zhao, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Chengke Xie, Cheng‐Yu Liao, Hong-Yi Lin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3

Exploring the role of m6A modification in cancer
Yongqi Wei, Yin Li, Chunlai Lu
PROTEOMICS (2022) Vol. 23, Iss. 13-14
Closed Access | Times Cited: 13

VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression
Jing Ji, Yuxin Xu, Mengru Xie, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 7

Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response
Mehrdad Hashemi, Padideh Daneii, Mohammad Arad Zandieh, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 84-104
Open Access | Times Cited: 7

IGF2BP2 regulates the inflammation of fibroblast-like synoviocytes via GSTM5 in rheumatoid arthritis
Yunyi Nan, Minhao Chen, Weijie Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top